Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | GRN | P28799 | 1/20 | 0.34 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.34 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12799252 | 0.79 | NAALAD2 (0.47) | NAALAD2APEX1ALDH1A1RECQLCYP1A2 | |
| SCHEMBL12799249 | 0.77 | NAALAD2 (0.49) | NAALAD2APEX1ALDH1A1RECQLCYP1A2 | |
| SCHEMBL7488458 | 0.75 | CYP1A2 (0.51) | NAALAD2APEX1ALDH1A1RECQLCYP1A2 | |
| SCHEMBL31326721 | 0.72 | NAALAD2 (0.44) | NAALAD2ALDH1A1RECQLCYP1A2GRN | |
| SCHEMBL23796262 | 0.68 | NAALAD2 (0.47) | NAALAD2ALDH1A1RECQLCYP1A2L3MBTL1 | |
| SCHEMBL23646039 | 0.67 | NAALAD2 (0.40) | NAALAD2ALDH1A1RECQLCYP1A2GRN | |
| SCHEMBL683290 | 0.66 | — | — | |
| SCHEMBL13319916 | 0.64 | NAALAD2 (0.44) | NAALAD2ALDH1A1RECQLCYP1A2PIN1 | |
| SCHEMBL2781606 | 0.64 | NAALAD2 (0.48) | NAALAD2ALDH1A1RECQLCYP1A2L3MBTL1 | |
| SCHEMBL19836248 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018057588-A1 | FURO[3,2-B]PYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2018-03-29 | — | — | WO | disclosed |